Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Rex

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Medical Mycology|March 13, 1999
Activated lymphocytes reduce adherence of Aspergillus fumigatusM D Martins, L J Rodriguez, C A Savary, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1997
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory StandardsJ H Rex, M A Pfaller, J N Galgiani, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 2, 2005
International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemiaL Ostrosky-Zeichner, D Kontoyiannis, J Raffalli, et al.
Journal of Clinical Microbiology|June 27, 2008
Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpointsM A Pfaller, D J Diekema, L Ostrosky-Zeichner, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2003
Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST)M Cuenca-Estrella, C B Moore, F Barchiesi, et al.
Cancer Immunology, Immunotherapy : CII|January 24, 1998
Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patientsC A Savary, M L Grazziutti, B Melichar, et al.
Npj Antimicrobials and Resistance|May 29, 2026
Addressing the dual-use of antifungals and fungal antimicrobial resistance (fAMR) through a One Health approachS Weeks, A Brown, K Doughty, et al.
Journal of Clinical Microbiology|March 7, 2006
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpointsM A Pfaller, D J Diekema, J H Rex, et al.
Lancet (London, England)|October 26, 2005
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trialB J Kullberg, J D Sobel, M Ruhnke, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 3, 2007
Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care settingL Ostrosky-Zeichner, C Sable, J Sobel, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Medical Mycology|March 13, 1999
Activated lymphocytes reduce adherence of Aspergillus fumigatusM D Martins, L J Rodriguez, C A Savary, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1997
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory StandardsJ H Rex, M A Pfaller, J N Galgiani, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 2, 2005
International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemiaL Ostrosky-Zeichner, D Kontoyiannis, J Raffalli, et al.
Journal of Clinical Microbiology|June 27, 2008
Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpointsM A Pfaller, D J Diekema, L Ostrosky-Zeichner, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2003
Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST)M Cuenca-Estrella, C B Moore, F Barchiesi, et al.
Cancer Immunology, Immunotherapy : CII|January 24, 1998
Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patientsC A Savary, M L Grazziutti, B Melichar, et al.
Npj Antimicrobials and Resistance|May 29, 2026
Addressing the dual-use of antifungals and fungal antimicrobial resistance (fAMR) through a One Health approachS Weeks, A Brown, K Doughty, et al.
Journal of Clinical Microbiology|March 7, 2006
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpointsM A Pfaller, D J Diekema, J H Rex, et al.
Lancet (London, England)|October 26, 2005
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trialB J Kullberg, J D Sobel, M Ruhnke, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 3, 2007
Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care settingL Ostrosky-Zeichner, C Sable, J Sobel, et al.
Pageof 11